1998
DOI: 10.1007/bf03347336
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults

Abstract: IGF-I is the best marker of GH secretory status but it also depends on the nutritional status and peripheral hormones such as insulin, glucocorticoids, thyroid hormones and gonadal steroids. Though monitoring IGF-I levels is the best way for evaluating appropriate GH replacement, the usefulness of IGF-I assay in the diagnosis of adult GH deficiency (GHD) is still matter of debate. To clarify this point in a large population of GHD adults (no. = 135, 61 women and 74 men; age, mean +/- SE: 43.8 +/- 1.4 yr, range… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
61
0

Year Published

1999
1999
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(65 citation statements)
references
References 23 publications
4
61
0
Order By: Relevance
“…First of all, we defined normative values for IGF1 with 95% specificity in a large series of healthy subjects; this allowed a strict definition of diseased subjects with serum IGF1 below the normal value for age. The fact that 82% of patients with total hypopituitarism had serum IGF1 below the normal range for age clearly indicates that measurement of IGF1 in this context is a good indicator of GHD, in keeping with previous reports (10,(23)(24)(25)(26)(27); moreover, our findings overtake any specific cut-off point and extend the concept that IGF1 below strictly defined normative range for age identified most GHD patients when applied in the appropriate clinical context. However, several points, including local specific cut-offs, should be taken into consideration for IGF1 measurements, as recently outlined (28).…”
Section: Discussionsupporting
confidence: 90%
“…First of all, we defined normative values for IGF1 with 95% specificity in a large series of healthy subjects; this allowed a strict definition of diseased subjects with serum IGF1 below the normal value for age. The fact that 82% of patients with total hypopituitarism had serum IGF1 below the normal range for age clearly indicates that measurement of IGF1 in this context is a good indicator of GHD, in keeping with previous reports (10,(23)(24)(25)(26)(27); moreover, our findings overtake any specific cut-off point and extend the concept that IGF1 below strictly defined normative range for age identified most GHD patients when applied in the appropriate clinical context. However, several points, including local specific cut-offs, should be taken into consideration for IGF1 measurements, as recently outlined (28).…”
Section: Discussionsupporting
confidence: 90%
“…Total IGF-I has good intra-individual reproducibility and it is positively associated with the peak GH response to provocative tests (20). Based on these studies, we agree on the proposal that adult patients, with 3 or more pituitary deficits and low IGF-I, provocative tests are useless for the diagnosis of GHD.…”
Section: Ghd Symptomssupporting
confidence: 66%
“…However, the reliability of serum IGF-1 as an indicator of GH deficiency is being debated (Aimaretti et al, 1998(Aimaretti et al, , 2003Granada et al, 2000). Specifically, the consensus guidelines for the diagnosis and treatment of adults with GH deficiency conclude that, ''a normal IGF-1 does not rule out GH deficiency'' (Ho, 2007).…”
Section: Kasturi and Steinmentioning
confidence: 99%